A1AWR
1-{(3S)-4-[(7M)-7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}quinazolin-4-yl]-3-methylpiperazin-1-yl}propan-1-one
| Created: | 2024-07-05 |
| Last modified: | 2024-12-11 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 77 |
| Chiral Atom Count | 2 |
| Bond Count | 81 |
| Aromatic Bond Count | 17 |
Chemical Component Summary | |
|---|---|
| Name | 1-{(3S)-4-[(7M)-7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}quinazolin-4-yl]-3-methylpiperazin-1-yl}propan-1-one |
| Synonyms | divarasib, bound form |
| Systematic Name (OpenEye OEToolkits) | 1-[(3~{S})-4-[7-[6-azanyl-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloranyl-8-fluoranyl-2-[[(2~{S})-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]-3-methyl-piperazin-1-yl]propan-1-one |
| Formula | C29 H34 Cl F4 N7 O2 |
| Molecular Weight | 624.073 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | CN1CCCC1COc1nc2c(F)c(c3nc(N)cc(C)c3C(F)(F)F)c(Cl)cc2c(n1)N1CCN(CC1C)C(=O)CC |
| SMILES | CACTVS | 3.385 | CCC(=O)N1CCN([CH](C)C1)c2nc(OC[CH]3CCCN3C)nc4c(F)c(c(Cl)cc24)c5nc(N)cc(C)c5C(F)(F)F |
| SMILES | OpenEye OEToolkits | 2.0.7 | CCC(=O)N1CCN(C(C1)C)c2c3cc(c(c(c3nc(n2)OCC4CCCN4C)F)c5c(c(cc(n5)N)C)C(F)(F)F)Cl |
| Canonical SMILES | CACTVS | 3.385 | CCC(=O)N1CCN([C@@H](C)C1)c2nc(OC[C@@H]3CCCN3C)nc4c(F)c(c(Cl)cc24)c5nc(N)cc(C)c5C(F)(F)F |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CCC(=O)N1CCN([C@H](C1)C)c2c3cc(c(c(c3nc(n2)OC[C@@H]4CCCN4C)F)c5c(c(cc(n5)N)C)C(F)(F)F)Cl |
| InChI | InChI | 1.06 | InChI=1S/C29H34ClF4N7O2/c1-5-21(42)40-9-10-41(16(3)13-40)27-18-12-19(30)22(26-23(29(32,33)34)15(2)11-20(35)36-26)24(31)25(18)37-28(38-27)43-14-17-7-6-8-39(17)4/h11-12,16-17H,5-10,13-14H2,1-4H3,(H2,35,36)/t16-,17-/m0/s1 |
| InChIKey | InChI | 1.06 | QEAJZIRHKLXVLR-IRXDYDNUSA-N |














